Total planned funding: $116,867,042
Allocations
Countries/Regions
India | $116,867,042 |
Organizational Types
NGO | $40,983,011 |
Unknown | $35,191,788 |
Own Agency | $20,065,743 |
University | $10,000,000 |
Implementing Agency | $3,100,000 |
Multi-lateral Agency | $2,860,000 |
Private Contractor | $1,650,000 |
FBO | $1,600,000 |
Host Country Government Agency | $1,009,200 |
Other USG Agency | $407,300 |
Program Areas
Governance and Systems | $48,836,554 |
Prevention | $27,503,628 |
Management and Operations | $14,402,455 |
Care | $14,056,599 |
Treatment | $6,674,108 |
Testing | $5,393,698 |
Budget Codes
OHSS: Health Systems Strengthening | $27,089,265 |
HVSI: Strategic Information | $17,462,305 |
HVOP: Sexual Prevention: Other Sexual Prevention | $15,966,077 |
HVMS: Management and Operations | $14,402,455 |
HBHC: Care: Adult Care and Support | $7,772,513 |
HTXS: Treatment: Adult Treatment | $6,167,613 |
HVCT: Testing: HIV Testing and Counseling | $5,393,698 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,153,396 |
HLAB: Laboratory Infrastructure | $4,284,984 |
HVTB: Care: TB/HIV | $3,258,745 |
HKID: Care: Orphans and Vulnerable Children | $2,683,308 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $2,655,156 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $2,429,346 |
HMBL: Biomedical Prevention: Blood Safety | $1,299,653 |
PDTX: Treatment: Pediatric Treatment | $483,018 |
PDCS: Care: Pediatric Care and Support | $342,033 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$34,144,299
Countries/Regions
FHI 360:
$15,965,228
Countries/Regions
USG Aggregated Agencies:
$11,570,590
Countries/Regions
Voluntary Health Services:
$8,030,000
Countries/Regions